SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    McGorry PD, Killackey E, Yung AR. Early intervention in psychotic disorders: detection and treatment of the first episode and the critical early stages. Med J Aust 2007; 187 : S8S10.
  • 2
    Yung AR, Phillips LJ, McGorry PD. Treating Schizophrenia in the Prodromal Phase. London: Taylor & Francis, 2004.
  • 3
    Yung AR, McGorry PD, Francey SM et al. PACE: a specialised service for young people at risk of psychotic disorders. Med J Aust 2007; 187 (7 Suppl.):S436.
  • 4
    Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001; 58 : 15864.
  • 5
    Schultze-Lutter F, Klosterkötter J, Picker H, Steinmeyer EM, Ruhrmann S. Predicting first-episode psychosis by basic symptom criteria. Clin Neuropsychiatry 2007; 4 : 1122.
  • 6
    Olsen KA, Rosenbaum B. Prospective investigations of the prodromal state of schizophrenia: review of studies. Acta Psychiatr Scand 2006; 113 : 24772.
  • 7
    Yung AR, Nelson B, Stanford C et al. Validation of ‘prodromal’ criteria to detect individuals at Ultra High Risk of psychosis: 2 year follow up. Schizophr Res 2008; 105 : 1017.
  • 8
    Yung AR, Yuen HP, Berger G et al. Declining transition rate in Ultra High Risk (prodromal) services: dilution or reduction of risk? Schizophr Bull 2007; 33 : 67381.
  • 9
    Cannon T, Cadenhead K, Cornblatt B et al. Prediction of psychosis in ultra high risk youth: a multi-site longitudinal study in North America. Arch Gen Psychiatry 2008; 65 : 2837.
  • 10
    Schultze-Lutter F. Subjective symptoms of schizophrenia in research and the clinic: the basic symptom concept. Schizophr Bull 2009; 35 : 59.
  • 11
    Yung AR, Yuen HP, McGorry PD et al. Mapping the onset of psychosis: the Comprehensive Assessment of At Risk Mental States (CAARMS). Aust N Z J Psychiatry 2005; 39 : 96471.
  • 12
    Miller TJ, Zipursky RB, Perkins D et al. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis: II Baseline characteristics of the ‘prodromal’ sample. Schizophr Res 2003; 61 : 1930.
  • 13
    Myles-Worsley M, Blailes F, Ord LM, Weaver S, Dever G, Faraone SV. The Palau early psychosis study: distribution of cases by level of genetic risk. Am J Med Genet B Neuropsychiatr Genet 2007; 144 : 59.
  • 14
    Riecher-Rössler A, Gschwandtner U, Aston J et al. The Basel early-detection-of-psychosis (FEPSY)-study: design and preliminary results. Acta Psychiatr Scand 2007; 115 : 11425.
  • 15
    Woods SW, Addington J, Cadenhead KS et al. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull 2009; 35 : 894908.
  • 16
    Hallmayer J. The epidemiology of the genetic liability for schizophrenia. Aust N Z J Psychiatry 2000; 34 : S47S55.
  • 17
    Tsuang M, Stone W, Faraone S. Genes, environment and schizophrenia. Br J Psychiatry 2001; 178 : s18s24.
  • 18
    Miller P, Lawrie SM, Hodges A, Clafferty R, Cosway R, Johnstone EC. Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia. Soc Psychiatry Psychiatr Epidemiol 2001; 36 : 33842.
  • 19
    Muñoz Maniega S, Lymer GK, Bastin ME et al. A diffusion tensor MRI study of white matter integrity in subjects at high genetic risk of schizophrenia. Schizophr Res 2008; 106 : 1329.
  • 20
    O'Connor M, Harris JM, McIntosh AM, Owens DG, Lawrie SM, Johnstone EC. Specific cognitive deficits in a group at genetic high risk of schizophrenia. Psychol Med 2009; 39 : 164955.
  • 21
    Johnstone EC, Ebmeier KB, Miller P, Owens DGC, Lawrie SM. Predicting schizophrenia: findings from the Edinburgh High-Risk Study. Br J Psychiatry 2005; 186 : 1825.
  • 22
    Whalley HC, Gountouna VE, Hall J et al. fMRI changes over time and reproducibility in unmedicated subjects at high genetic risk of schizophrenia. Psychol Med 2008; 39 : 118999.
  • 23
    McGorry PD, Purcell R, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging: a heuristic model for psychiatry and youth mental health. Med J Aust 2007; 187 (7 Suppl.):S402.
  • 24
    Henquet C, Krabbendam L, Spauwen J et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005; 330 : 115.
  • 25
    Kristensen K, Cadenhead KS. Cannabis abuse and risk for psychosis in a prodromal sample. Psychiatry Res 2007; 151 : 1514.
  • 26
    Verdoux H, Sorbara F, Gindre C, Swendsen JD, Van Os J. Cannabis use and dimensions of psychosis in a nonclinical population of female subjects. Schizophr Res 2003; 59 : 7784.
  • 27
    Gourzis P, Datrivanou A, Beratis S. Symptomatology of the initial prodromal phase in schizophrenia. Schizophr Bull 2002; 28 : 41529.
  • 28
    Tan H-Y, Ang Y-G. First episode psychosis in the military: a comparative study of prodromal symptoms. Aust N Z J Psychiatry 2001; 35 : 51219.
  • 29
    Norman RMG, Scholten DJ, Malla AK, Ballageer T. Early signs in schizophrenia spectrum disorder. J Nerv Ment Dis 2005; 193 : 1723.
  • 30
    Myles-Worsley M, Coon H, Tiobech J et al. A genetic epidemiological study of schizophrenia in Palau, Micronesia: prevalence and familiality. Am J Med Genet B Neuropsychiatr Genet 1999; 88 : 410.
  • 31
    Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 1978; 35 : 83744.
  • 32
    Kessler RC, Berglund P, Demler O, Jin R, Walters EE. Lifetime prevalence and age-of-onset distributions' of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 2005; 62 : 593602.
  • 33
    Paus T, Keshavan M, Giedd JN. Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci 2008; 9 : 94757.
  • 34
    Reinherz HZ, Paradis AD, Giaconia RM, Stashwick CK, Fitzmaurice G. Childhood and adolescent predictors of major depression in the transition to adulthood. Am J Psychiatry 2003; 160 : 21417.
  • 35
    Biederman J, Petty C, Faraone SV, Seidman L. Phenomenology of childhood psychosis: findings from a large sample of psychiatrically referred youth. J Nerv Ment Dis 2004; 192 : 60714.
  • 36
    Rapoport JL, Inoff-Germain G. Update on childhood-onset schizophrenia. Curr Psychiatry Rep 2000; 2 : 41015.
  • 37
    Kaufman J, Birmah B, Brent D et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36 : 9808.
  • 38
    Fendrich M, Warner V. Symptom and substance use reporting consistency over two years for offspring at high and low risk for depression. J Abnorm Child Psychol 1994; 22 : 42539.
  • 39
    Fendrich M, Weissman M, Warner V, Mufson L. Two-year recall of lifetime diagnoses in offspring at high and low risk for major depression: the stability of offspring reports. Arch Gen Psychiatry 1990; 47 : 11217.
  • 40
    Pressley M, Schneider W. Introduction to Memory Development during Childhood and Adolescence. Mahwah, NJ: Lawrence Erlbaum, 1997.
  • 41
    Hollis C. Adult outcomes of child- and adolescent-onset schizophrenia: diagnostic stability and predictive validity. Am J Psychiatry 2000; 157 : 16529.
  • 42
    Muratori F, Salvadori F, D'Arcangelo G, Viglione V, Picchi L. Childhood psychopathological antecedents in early onset schizophrenia. Eur Psychiatry 2005; 20 : 30914.
  • 43
    Poulton R, Caspi A, Moffitt TE, Cannon M, Murray R, Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch Gen Psychiatry 2000; 57 : 10538.
  • 44
    Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull 1996; 22 : 35370.
  • 45
    Rescorla L, Achenbach T, Ivanova M et al. Epidemiological comparisons of problems and positive qualities reported by adolescents in 24 countries. J Consult Clin Psychol 2007; 75 : 3518.
  • 46
    Rubenstein DH. Youth suicide and social change in Micronesia. Occas Pap 2002; 36 : 3342.
  • 47
    Yung AR, Phillips LJ, Yuen HP, McGorry PD, Francey SF, McFarlane CA. Psychosis prediction: 12 month follow-up of a high risk (‘prodromal’) group. Schizophr Res 2003; 60 : 2132.
  • 48
    Pineda D, Ardila A, Rosselli M et al. Prevalence of attention-deficit/hyperactivity disorder symptoms in 4- to 17-year-old children in the general population. J Abnorm Child Psychol 1999; 27 : 45562.
  • 49
    Mayoral M, Zabala A, Robles O et al. Neuropsychological functioning in adolescents with first episode psychosis: a two-year follow-up study. Eur Psychiatry 2008; 23 : 37583.
  • 50
    McClellan J, Prezbindowski A, Breiger D, McCurry C. Neuropsychological functioning in early onset psychotic disorders. Schizophr Res 2004; 68 : 216.
  • 51
    Arseneault L, Cannon M, Witton J, Murray RM. Casual association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 2002; 184 : 11017.
  • 52
    Ord LM, Myles-Worsley M, Blailes F, Ngiralmau H. Screening for prodromal adolescents in an isolated high-risk population. Schizophr Res 2004; 71 : 5078.